VivoSeq
Other

Acceptability

0

Pipeline Programs↗

5

Active Trials↗

11

Companies Involved↗

Acceptability is an early-stage landscape with 0 programs across 11 companies. The most active players are Sanofi, Bayer, Johnson & Johnson.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

92/100

Attrition Rate

7/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Sanofi logo

Sanofi

0 programs

PreclinicalBayer logo

Bayer

0 programs

PreclinicalJohnson & Johnson logo

Johnson & Johnson

0 programs

PreclinicalFerring logo

Ferring

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalP

Primus Pharmaceuticals

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

97

clinical trials

Completed81 · 84%
Unknown status4 · 4%
Withdrawn4 · 4%
Recruiting3 · 3%
Terminated3 · 3%
Active, not recruiting1 · 1%
Other1 · 1%

Clinical Trials

Trial Activity

97 trials

Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive
Recruiting·LLeiden University Medical Center·Phase 3·NCT06394999·1,186 enrolled
A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide
Recruiting·TTASK Applied Science·Phase 2·NCT06748937·60 enrolled
Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.
Recruiting·AANRS, Emerging Infectious Diseases·Phase 3·NCT05813964·524 enrolled
Acceptability of the HPV Vaccine and Anal HPV in Transgender Women and Men Who Have Sex With Men: A Pilot Study
Active, not recruiting·FFundación Huésped·Phase 4·NCT06588257·101 enrolled
Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens
Not yet recruiting·GGynuity Health Projects·Phase 2/3·NCT06492889·286 enrolled
Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power
Completed·Sanofi logoSanofi·Phase 3·NCT00687037·30 enrolled
Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC
Completed·—·Phase 2·NCT06184399·260 enrolled
A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution
Completed·NNorgine·Phase 3·NCT00389233·360 enrolled
Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata Pocket BR
Completed·Sanofi logoSanofi·Phase 3·NCT00663390·30 enrolled
Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis
Completed·PPATH·Phase 2·NCT02165202·136 enrolled
Acceptability of the NuvaRing Among Students
Completed·UUniversity of Chicago·Phase 4·NCT00635570·273 enrolled
Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)
Completed·IIndivior Inc.·N/A·NCT00723749·384 enrolled
Dermacyd Breeze Pocket BR (Lactic Acid) - Acceptability
Completed·Sanofi logoSanofi·Phase 3·NCT00793026·30 enrolled
Safety and Acceptability of SPL7013 Gel (VivaGel™) in Sexually Active Women
Completed·SStarpharma Pty Ltd·Phase 1·NCT00442910·61 enrolled
A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED)
Completed·Merck & Co. logoMerck & Co.·Phase 4·NCT00604188·188 enrolled
Page 1 of 7

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)